JC: Hydroxychloroquine in the the treatment of hospitalised COVID19 patients.

We previously covered the RECOVERY trial press release on the use of HCQ for hospitalised patients with COVID19. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with Covid-19. It’s an open label RCT that was developed out of the concepts behind the ASAP trial​1​. ASAP was … Continue reading JC: Hydroxychloroquine in the the treatment of hospitalised COVID19 patients.